These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10164064)

  • 21. Atopic dermatitis is associated with a decrement in health-related quality of life.
    Kiebert G; Sorensen SV; Revicki D; Fagan SC; Doyle JJ; Cohen J; Fivenson D
    Int J Dermatol; 2002 Mar; 41(3):151-8. PubMed ID: 12010340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature.
    Bronsard V; Paul C; Prey S; Puzenat E; Gourraud PA; Aractingi S; Aubin F; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Richard-Lallemand MA; Ortonne JP
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():17-22. PubMed ID: 20443996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group.
    Badia X; Mascaró JM; Lozano R
    Br J Dermatol; 1999 Oct; 141(4):698-702. PubMed ID: 10583119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the Dermatology Life Quality Index (DLQI) underestimate the disease-specific burden of psoriasis patients?
    Langenbruch A; Radtke MA; Gutknecht M; Augustin M
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):123-127. PubMed ID: 30160802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress.
    Fortune DG; Main CJ; O'Sullivan TM; Griffiths CE
    Br J Dermatol; 1997 Nov; 137(5):755-60. PubMed ID: 9415236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review.
    De Korte J; Mombers FM; Sprangers MA; Bos JD
    Arch Dermatol; 2002 Sep; 138(9):1221-7; discussion 1227. PubMed ID: 12224984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between Dermatology Life Quality Index (DLQI) scores and Work Limitations Questionnaire (WLQ) allows the calculation of percent work productivity loss in patients with psoriasis.
    Schmitt J; Küster D
    Arch Dermatol Res; 2015 Jul; 307(5):451-3. PubMed ID: 25940274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation and normative data of health status measures in older people: the Islington study.
    Pettit T; Livingston G; Manela M; Kitchen G; Katona C; Bowling A
    Int J Geriatr Psychiatry; 2001 Nov; 16(11):1061-70. PubMed ID: 11746652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity.
    Lundberg L; Johannesson M; Silverdahl M; Hermansson C; Lindberg M
    Acta Derm Venereol; 2000; 80(6):430-4. PubMed ID: 11243637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between quality of life and the severity of psoriasis in Turkey.
    Çakmur H; Derviş E
    Eur J Dermatol; 2015 Apr; 25(2):169-76. PubMed ID: 25655046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the correlation between scales determining disease severity in patients with moderate-severe chronic plaque-type psoriasis.
    Gundogdu M; Kundakci N
    J Cosmet Dermatol; 2021 Jul; 20(7):2328-2331. PubMed ID: 33142051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-cultural inequivalence of dermatology-specific health-related quality of life instruments in psoriasis patients.
    Nijsten T; Meads DM; de Korte J; Sampogna F; Gelfand JM; Ongenae K; Evers AW; Augustin M
    J Invest Dermatol; 2007 Oct; 127(10):2315-22. PubMed ID: 17495953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ISA247: quality of life results from a phase II, randomized, placebo-controlled study.
    Gupta AK; Langley RG; Lynde C; Barber K; Gulliver W; Lauzon G; Aspeslet LJ; Foster RT; Huizinga RB; Yatscoff RW
    J Cutan Med Surg; 2008; 12(6):268-75. PubMed ID: 19317948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Changes in Psoriasis Area and Severity Index by Body Region on Quality of Life in Patients with Psoriasis.
    Sojević Timotijević Z; Majcan P; Trajković G; Relić M; Novaković T; Mirković M; Djurić S; Nikolić S; Lazić B; Janković S
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):215-222. PubMed ID: 29252174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Qualitative assessment of the content validity of the Dermatology Life Quality Index in patients with moderate to severe psoriasis.
    Safikhani S; Sundaram M; Bao Y; Mulani P; Revicki DA
    J Dermatolog Treat; 2013 Feb; 24(1):50-9. PubMed ID: 22007701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study.
    Cozzani E; Linder D; Burlando M; Gallo F; Sampogna F; Bruzzone M; Tacchino C; Drago F; Parodi A
    Eur J Dermatol; 2018 Jun; 28(3):332-337. PubMed ID: 29789272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the SF-12 questionnaire to assess physical and mental health status in patients with psoriasis.
    Sampogna F; Mastroeni S; Pallotta S; Fusari R; Uras C; Napolitano M; Abeni D
    J Dermatol; 2019 Dec; 46(12):1153-1159. PubMed ID: 31608501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychometric properties of the psoriasis disability index in United States patients.
    Nijsten T; Whalley D; Gelfand J; Margolis D; McKenna SP; Stern RS
    J Invest Dermatol; 2005 Oct; 125(4):665-72. PubMed ID: 16185264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Frequency of "Not Relevant" Responses on the Dermatology Life Quality Index by Sociodemographic Characteristics of Patients With Psoriasis.
    Barbieri JS; Shin DB; Syed MN; Takeshita J; Gelfand JM
    JAMA Dermatol; 2020 Apr; 156(4):446-450. PubMed ID: 32101261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of adalimumab treatment on patient-reported outcomes: results from a Phase III clinical trial in patients with moderate to severe plaque psoriasis.
    Revicki DA; Willian MK; Menter A; Gordon KB; Kimball AB; Leonardi CL; Langley RG; Kimel M; Okun M
    J Dermatolog Treat; 2007; 18(6):341-50. PubMed ID: 18058494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.